# Repro Lab, Inc. – FDA Inspection, Nov 19, 2024

Source: https://www.keypedia.com/records/fda_inspections/repro-lab-inc/14a1802d-30a7-4b9c-9b55-a256b7aad146
Source feed: FDA_Inspections

> FDA inspection 1255573 of Repro Lab, Inc., November 19, 2024. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 1271. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1255573
- Company Name: Repro Lab, Inc.
- Inspection Date: 2024-11-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: New York District Office
- Citation Count: 2

## Related Documents

- FDA Inspection 1172852 - 2022-06-24
- FDA Inspection 1131538 - 2020-10-16
- [FDA Inspection 1045046 - 2018-03-19](https://www.keypedia.com/records/fda_inspections/repro-lab-inc/e84b0b3b-f6c1-44a9-9b55-1b795fdd531d)
- [FDA Inspection 961911 - 2016-03-08](https://www.keypedia.com/records/fda_inspections/repro-lab-inc/40330317-aa57-45bd-b4d0-311c314ed545)
- FDA Inspection 895463 - 2014-09-17

## Related Officers

- [Amy Kim](https://www.keypedia.com/people/amy-kim/eee8b97a-b9d0-4709-96dc-70dbadd3a6a4)

Company: https://www.keypedia.com/companies/repro-lab-inc/8960714b-ecb8-4b1d-80ad-c0ad8cb96afe

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d